塞力斯,603716,收入构成,报告日期,2018-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 体外诊断仪器设备,2366,1996,370,15.63%,0.88% 诊断试剂及耗材,129379,87949,41430,32.02%,99.12% 塞力斯,603716,收入构成,报告日期,2018-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 仪器,694,663,31,4.49%,0.16% 试剂及耗材,56628,37408,19220,33.94%,99.84% 其他,128,-- ,-- ,--,0% 塞力斯,603716,收入构成,报告日期,2017-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 集约化销售商品,74232,50414,23818,32.09%,76.81% 单纯销售商品,17819,10630,7189,40.35%,23.19% 塞力斯,603716,收入构成,报告日期,2016-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 集约化销售业务,57609,37933,19677,34.16%,90.06% 单纯销售业务,5123,2952,2171,42.38%,9.94% 塞力斯,603716,收入构成,报告日期,2016-06-30, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 集约化销售业务,26823,17294,9529,35.53%,79.39% 其中:外购仪器设备,222,170,52,23.49%,0.43% 其中:自产试剂和耗材,557,140,418,74.93%,3.48% 其中:外购试剂和耗材,1795,1028,767,42.73%,6.39% 单纯销售业务,2574,1338,1237,48.04%,10.3% 塞力斯,603716,收入构成,报告日期,2015-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 集约化销售业务,46541,30288,16253,34.92%,76.68% 其中:外购仪器设备,1540,1241,298,19.38%,1.41% 其中:自产试剂和耗材,1161,277,884,76.13%,4.17% 其中:外购试剂和耗材,3724,2435,1289,34.61%,6.08% 单纯销售业务,6425,3954,2471,38.46%,11.66% 塞力斯,603716,收入构成,报告日期,2014-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 集约化销售业务,37842,24317,13525,35.74%,70.47% 其中:外购仪器设备,719,558,160,22.33%,0.84% 其中:自产试剂和耗材,1215,276,938,77.27%,4.89% 其中:外购试剂和耗材,4729,2994,1735,36.69%,9.04% 单纯销售业务,6663,3829,2834,42.54%,14.77% 塞力斯,603716,收入构成,报告日期,2013-12-31, 按产品,收入(万元),成本(万元),利润(万元),毛利率,利润占比 集约化销售业务,27759,17361,10398,37.46%,55.45% 其中:外购仪器设备,4229,3240,988,23.37%,5.27% 其中:自产试剂和耗材,1143,314,829,72.56%,4.42% 其中:外购试剂和耗材,6087,3728,2359,38.75%,12.58% 单纯销售业务,11459,7282,4176,36.45%,22.27%